Drug intelligence / Profile preview

ofloxacin + fluocinolone acetonide

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Ophthalmic, Otic
01

Overview

Ofloxacin + fluocinolone acetonide is a combination topical drug used primarily to treat **bacterial ear infections** and **skin infections** accompanied by significant inflammation and itching. **Ofloxacin** is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, blocking DNA replication and leading to bacterial cell death. **Fluocinolone acetonide** is a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Together, this combination addresses infection and reduces inflammation for rapid symptom relief. It is most commonly supplied as ear drops or skin preparations for external use. The combination is typically marketed for otitis externa (outer ear infection), mixed microbial ear or skin infections, and conditions characterized by both infection and inflammation[3].

02

Targets

DNA gyraseTopo IV (Bacterial Topoisomerase IV)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on ofloxacin + fluocinolone acetonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ofloxacin + fluocinolone acetonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call